Potts v. Takeda Pharmaceutical Company Limited et al
| Wayne Potts |
| Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals U.S.A., Inc. and Takeda Pharmaceuticals America, Inc. |
| 1:2019cv08171 |
| December 13, 2019 |
| US District Court for the Northern District of Illinois |
| Robert W Gettleman |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1332 |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on February 5, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 19 CASE MANAGEMENT ORDER NO. 1 (establishing master case file, consolidating cases for pretrial purposes,and establishing coordinated discovery and pretrial schedule): Signed by the Honorable Matthew F. Kennelly on 2/5/2020. Mailed notice. (mma, ) |
Filing 18
EXECUTIVE COMMITTEE ORDER: It appearing that, for reasons of judicial efficiency, coordinated pretrial proceedings in the cases listed below should be presided over by a single district judge as provided for by IOP13(e) and that a single magistrate judge should be designated for these cases; and It further appearing that the Hon. Matthew F. Kennelly, has agreed to preside over these proceedings; and It further appearing that Magistrate Judge Young B. Kim has agreed to be the designated magistrate judge in these proceedings; therefore It is hereby ordered that Judge Kennelly shall preside over pretrial proceedings, including case management and discovery supervision, in the cases listed below; and It is further ordered that Magistrate Judge Kim shall be the designated magistrate judge; and It is further ordered that these cases shall remain pending on the calendars of the judges to whom they are currently assigned, and that an order be entered in each case by Judge Kennelly at such time as coordinated pretrial proceedings have concluded; and It is further ordered that the Clerk of Court shall open a new civil case (20 CV 623, In Re: Uloric Products Liability Coordinated Pretrial Proceedings) under which all future filings related to these coordinated pretrial proceedings shall be filed; and It is further ordered that the Clerk of Court shall link the individual cases listed below to 20 CV 623, In Re: Uloric Products Liability Coordinated Pretrial Proceedings. Signed by the Executive Committee on 1/28/2020. Mailed notice(gcy, )
|
| Filing 17 MINUTE entry before the Honorable Matthew F. Kennelly: Rule 16(b) status hearing held on 1/28/2020 with attorneys for all parties in all coordinated cases. The Court will establish a single case number for all future common filings. The Court approves the parties' status report and proposed schedule. A scheduling order will be entered once the single coordinated case number is established. Mailed notice. (mma, ) |
| Filing 16 ATTORNEY Appearance for Plaintiff Wayne Potts by Molly Lorraine Condon (Condon, Molly) |
|
Filing 15
ORDER Regarding the Protocol for Production of Electronically Stored Information and Hardcopy Documents: Signed by the Honorable Matthew F. Kennelly on 1/9/2020. Mailed notice. (mma, )
|
| Filing 14 STIPULATED PROTECTIVE ORDER OF CONFIDENTIALITY: Signed by the Honorable Matthew F. Kennelly on 1/9/2020. Mailed notice. (mma, ) |
| Filing 13 MINUTE entry before the Honorable Matthew F. Kennelly: Joint case management conference held in this and other cases referred to Judge Kennelly for pretrial case management purposes under Internal Operating Procedure 13(e). Any obligation to comply with the Mandatory Initial Discovery Pilot Project's requirements is hereby vacated. The parties are directed to confer regarding a single, common case management schedule for all cases that are subject to the IOP 13(e) referral, a form of plaintiff's fact sheet, and other pertinent case management matters. A joint status report with the parties' joint or separate proposals, including as exhibits any proposed plaintiff's fact sheets and proposed orders, is to be filed under Case No. 19 C 4347 only by 1/24/2020. The proposed agreed confidentiality and ESI orders are to be modified to include the captions for all of the cases subject to the IOP 13(e) referral and are to be submitted in Word format to Judge Kennelly's proposed order e-mail address. A further joint case management conference before Judge Kennelly is set for 1/28/2020 at 8:45 AM. (mk) |
|
Filing 12
EXECUTIVE COMMITTEE ORDER: It appearing that, for reasons of judicial efficiency, coordinated pretrial proceedings in the cases listed below should be presided over by a single district judge as provided for by IOP13(e) and that a single magistrate judge should be designated for these cases; and It further appearing that the Hon. Matthew F. Kennelly, has agreed to preside over these proceedings; and It further appearing that Magistrate Judge Young B. Kim has agreed to be the designated magistrate judge in these proceedings; therefore It is hereby ordered that Judge Kennelly shall preside over pretrial proceedings, including case management and discovery supervision, in the cases listed below; and It is further ordered that Magistrate Judge Kim shall be the designated magistrate judge; and It is further ordered that these cases shall remain pending on the calendars of the judges to whom they are currently assigned, and that an order be entered in each case by Judge Kennelly at such time as coordinated pretrial proceedings have concluded. Signed by the Executive Committee on 1/7/2020. (td, )
|
| Filing 11 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc. (Hemmings, James) |
| Filing 10 ANSWER to Complaint with Jury Demand and Separate or Affirmative Defenses by Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc.(Hemmings, James) |
| Filing 9 ATTORNEY Appearance for Defendants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc. by James R M Hemmings (Hemmings, James) |
| Filing 8 ATTORNEY Appearance for Defendants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc. by Andrea Marie Glinka Przybysz (Glinka Przybysz, Andrea) |
| Filing 7 ATTORNEY Appearance for Defendants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc. by Sherry Ann Knutson (Knutson, Sherry) |
| Filing 6 SUMMONS Returned Executed by Wayne Potts as to Takeda Pharmaceuticals America, Inc. on 12/17/2019, answer due 1/7/2020. (Wallace, Edward) |
| Filing 5 SUMMONS Returned Executed by Wayne Potts as to Takeda Pharmaceuticals U.S.A., Inc. on 12/17/2019, answer due 1/7/2020. (Wallace, Edward) |
| SUMMONS Issued as to Defendants Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc. (kl, ) |
| Filing 4 Notice of Related Case Pursuant to L.R. 40.4 by Wayne Potts (Wallace, Edward) |
| Filing 3 ATTORNEY Appearance for Plaintiff Wayne Potts by Umar Sattar (Sattar, Umar) |
| Filing 2 ATTORNEY Appearance for Plaintiff Wayne Potts by Edward A. Wallace (Wallace, Edward) |
| Filing 1 COMPLAINT filed by Wayne Potts; Jury Demand. Filing fee $ 400, receipt number 0752-16531000. (Attachments: #1 Civil Cover Sheet)(Wallace, Edward) |
| CASE ASSIGNED to the Honorable Robert W. Gettleman. Designated as Magistrate Judge the Honorable Young B. Kim. Case assignment: Random assignment. (txl, ) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Illinois Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
